AUA annual meeting featured a kidney cancer session and a presentation by Dr. Pratik Kanabur discussing a cost-effectiveness analysis of 89 Zr-girentuximab PET-CT (TLX250) to guide management of small ...

Despite the use of real-time ultrasound and spring-loaded biopsy needles, the frequency of clinically significant bleeding after kidney biopsy is approximately 3–12%, with up to 6% of all ...